Royalty Pharma Reports Second Quarter 2024 Results

Go back to Royalty Pharma Reports Second Quarter 2024 Results
REPROS THERAPEUTICS (NASDAQ: RPRX) Delayed: 58.75 --0 (-0%)
Previous Close $58.75    52 Week High $3.48 
Open $58.75    52 Week Low $0.80 
Day High $58.75    P/E N/A 
Day Low $58.75    EPS $-1.54 
Volume 5,060